Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016


July 7, 2010
51 Pages - SKU: GBDT2740122
License type:
Table of Contents Search inside this report Related Reports Detailed Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction and Overview
2.1 GlobalData Research Guidance
3 Disease Overview: Diabetes
3.1 Type I Diabetes
3.1.1 Introduction
3.1.2 Etiology, Disease Symptoms and Risk Factors
3.1.3 Pathophysiology
3.1.4 Epidemiology
3.1.5 Device Based Disease Treatment and Management: Insulin Delivery
3.2 Type 2 Diabetes
3.2.1 Introduction
3.2.2 Etiology, Disease Symptoms and Risk Factors
3.2.3 Pathophysiology
3.2.4 Epidemiology
3.2.5 Device Based Disease Treatment and Management:
4 Diabetes Care Devices, Emerging Markets: Market Characterization
4.1 Diabetes Care Devices, Emerging Markets, Historic Revenues ($m), 2002 - 2009
4.2 Diabetes Care Devices, Emerging Markets, Forecast Revenues ($m), 2009 - 2016
4.3 Diabetes Care Devices, Emerging Markets, Key Company Shares
4.4 Diabetes Care Devices, Emerging Markets, Key Market Trends
4.4.1 Increased Government Programs for Diabetes Care Awareness
4.4.2 Localization of Manufacturing of Diabetes Care Devices by Big Players
4.5 Diabetes Care Devices, Emerging Markets, Market Dynamics
4.5.1 Market Drivers
4.5.2 Market Restraints
5 Glucose Monitoring, Emerging Markets: Market Characterization
5.1 Glucose Monitoring Strips, Emerging Markets, Historic Revenues ($m), 2002 - 2009
5.2 Glucose Monitoring Strips, Emerging Markets, Forecast Revenue ($m), 2009 - 2016
5.3 Blood Glucose Meters, Emerging Markets, Historic Revenues ($m), 2002 - 2009
5.4 Blood Glucose Meters, Emerging Markets, Forecast Revenues ($m), 2009 - 2016
5.5 Glucose Monitoring, Emerging Markets, Market Dynamics
5.5.1 Market Drivers
5.5.2 Market Restraints
5.6 Glucose Monitoring, Emerging Markets, Key Company Shares
5.6.1 Glucose Monitoring, China, Key Company Shares, 2009
5.6.2 Glucose Monitoring, India, Key Company Shares, 2009
5.6.3 Glucose Monitoring, Brazil, Key Company Shares 2009
6 Insulin Delivery, Emerging Markets: Market Characterization
6.1 Insulin Syringes, Emerging Markets, Historic Revenues ($m), 2002 - 2009
6.2 Insulin Syringes, Emerging Markets, Forecast Revenues ($m), 2009 - 2016
6.3 Insulin Pens, Emerging Markets, Historic Revenues ($m), 2002 - 2009
6.4 Insulin Pens, Emerging Markets, Forecast Revenues ($m), 2009 - 2016
6.5 Insulin Pumps, Emerging Markets, Historic Revenues ($m), 2002 - 2009
6.6 Insulin Pumps, Emerging Markets, Forecast Revenues ($m), 2009 - 2016
6.7 Insulin Pump Accessories, Emerging Markets, Historic Revenues ($m), 2002 - 2009
6.8 Insulin Pump Accessories, Emerging Markets, Forecast Revenues ($m), 2009 - 2016
6.9 Insulin Delivery, Emerging Markets, Market Dynamics
6.9.1 Market Drivers
6.9.2 Market Restraints
6.10 Insulin Delivery, Emerging Markets, Key Company Shares, 2009
6.10.1 Insulin Delivery, China, Key Company Shares, 2009
6.10.2 Insulin Delivery, India, Key Company Shares 2009
6.10.3 Insulin Delivery, Brazil, Key Company Shares 2009
7 Diabetes Care Devices, Emerging Markets: Key Market Participants
7.1 Glucose Monitoring Devices Market
7.2 Insulin Delivery Devices Market
7.3 Company Profiles
7.3.1 F. Hoffmann-La Roche Ltd
7.3.2 LifeScan (Johnson & Johnson)
7.3.3 Bayer Healthcare
7.3.4 Abbott Laboratories
7.3.5 Becton, Dickinson and Company
7.3.6 Medtronic
7.3.7 Novo Nordisk
7.3.8 Other Companies
8 Appendix
8.1 Acronyms
8.2 Sources
8.3 Database
8.4 Research Methodology
8.5 Secondary Research
8.6 Primary Research
8.7 Models
8.8 Forecasts
8.9 Expert Panels
8.10 GlobalData Consulting
8.11 Contact Us
8.12 Disclaimer
1.1 List of Tables
Table 1: Incidence: New Cases of Type 1 Diabetes in Children (under 14 years) 2010
Table 2: Epidemiology: Percent of with Diabetes (20-79 years), 2010 (national)
Table 3: Diabetes Care Devices, Emerging Markets, Historic Revenues ($m), 2002 - 2009
Table 4: Diabetes Care Devices, Emerging Markets, Forecast Revenues ($m), 2009 - 2016
Table 5: Diabetes Care Devices, China, Key Company Revenue ($m), 2009
Table 6: Diabetes Care Devices, India, Key Company Revenue ($m), 2009
Table 7: Diabetes Care Devices, Brazil, Key Company Revenue ($m), 2009
Table 8: Glucose Monitoring Strips, Emerging Markets, Historic Revenues ($m), 2002 - 2009
Table 9: Glucose Monitoring Strips, Emerging Markets, Forecast Revenues ($m), 2009 - 2016
Table 10: Blood Glucose Meters, Emerging Markets, Historic Revenues ($m), 2002 - 2009
Table 11: Blood Glucose Meters, Emerging Markets, Forecast Revenues ($m), 2009 - 2016
Table 12: Glucose Monitoring, China, Key Company Revenue ($m), 2009
Table 13: Glucose Monitoring, India, Key Company Revenue ($m), 2009
Table 14: Glucose Monitoring, Brazil, Key Company Revenue ($m), 2009
Table 15: Insulin Syringes, Emerging Markets, Historic Revenues ($m), 2002 - 2009
Table 16: Insulin Syringes, Emerging Markets, Forecast Revenues ($m), 2009 - 2016
Table 17: Insulin Pens, Emerging Markets, Historic Revenues ($m), 2002 - 2009
Table 18: Insulin Pens, Emerging Markets, Forecast Revenues ($m), 2009 - 2016
Table 19: Insulin Pumps, Emerging Markets, Historic Revenues ($m), 2002 - 2009
Table 20: Insulin Pumps, Emerging Markets, Forecasts Revenues ($m), 2009 - 2016
Table 21: Insulin Pump Accessories, Emerging Markets, Historic Revenues ($m), 2002 - 2009
Table 22: Insulin Pump Accessories, Emerging Markets, Forecast Revenues ($m), 2009 - 2016
Table 23: Insulin Delivery, China, Key Company Revenue ($m), 2009
Table 24: Insulin Delivery, India, Key Company Revenue ($m), 2009
Table 25: Insulin Delivery, Brazil, Key Company Revenue ($m), 2009
Table 26: F Hoffman-La Roche, Key Marketed Products, Emerging Markets, 2010
Table 27: Johnson & Johnson, Key Marketed Products, Emerging Markets, 2010
Table 28: Bayer Healthcare, Key Marketed Products, Emerging Markets, 2010
Table 29: Abbott Laboratories, Key Marketed Products, Emerging Markets, 2010
Table 30: Becton Dickinson & Company, Key Marketed Products, Emerging Markets, 2010
Table 31: Medtronic, Key Marketed Products, Emerging Markets, 2010
Table 32: NovoNordisk, Key Marketed Products, Emerging Markets, 2010
Table 33: Local Diabetes Care Device Companies in China and India
1.2 List of Figures
Figure 1: Incidence: New Cases of Type 1 Diabetes in Children (under 14 years) 2010
Figure 2: Epidemiology: Percent of with Diabetes (20-79 years), 2010 (national)
Figure 3: Diabetes Care Devices, Emerging Markets,Historic Revenues ($m), 2002 - 2009
Figure 4: Diabetes Care Devices, Emerging Markets, Forecast Revenues ($m), 2009 - 2016
Figure 5: Diabetes Care Devices, China, Key Company Shares, 2009
Figure 6: Diabetes Care Devices, India, Key Company Shares, 2009
Figure 7: Diabetes Care Devices, Brazil, Key Company Shares, 2009
Figure 8: Glucose Monitoring Strips, Emerging Markets, Historic Revenues ($m), 2002 - 2009
Figure 9: Glucose Monitoring Strips, Emerging Markets, Forecast Revenues ($m), 2009 - 2016
Figure 10: Blood Glucose Meters, Emerging Markets, Historic Revenues ($m), 2002 - 2009
Figure 11: Blood Glucose Meters, Emerging Markets, Forecast Revenues ($m), 2009 - 2016
Figure 12: Glucose Monitoring, China, Key Company Shares, 2009
Figure 13: Glucose Monitoring, India, Key Company Shares, 2009
Figure 14: Glucose Monitoring, Brazil, Key Company Shares, 2009
Figure 15: Insulin Syringes, Emerging Markets, Historic Revenues ($m), 2002 - 2009
Figure 16: Insulin Syringes, Emerging Markets, Forecast Revenues ($m), 2009 - 2016
Figure 17: Insulin Pens, Emerging Markets, Historic Revenues ($m), 2002 - 2009
Figure 18: Insulin Pens, Emerging Markets, Forecast Revenues ($m), 2009 - 2016
Figure 19: Insulin Pumps, Emerging Markets, Historic Revenues ($m), 2002 - 2009
Figure 20: Insulin Pumps, Emerging Markets, Forecasts Revenues ($m), 2009 - 2016
Figure 21: Insulin Pump Accessories, Emerging Markets, Historic Revenues ($m), 2002 - 2009
Figure 22: Insulin Pump Accessories, Emerging Markets, Forecast Revenues ($m),2009 - 2016
Figure 23: Insulin Delivery, China, Key Company Shares, 2009
Figure 24: Insulin Delivery, India, Key Company Shares, 2009
Figure 25: Insulin Delivery, Brazil, Key Company Shares, 2009
Figure 26: GlobalData Methodology
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Diabetes Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!